Calendar Virpax Pharmaceuticals, Inc.

Equities

VRPX

US9282512063

Market Closed - Nasdaq 04:30:01 2024-04-26 pm EDT 5-day change 1st Jan Change
3.1 USD +6.22% Intraday chart for Virpax Pharmaceuticals, Inc. -15.76% -3.16%

Chart calendar Virpax Pharmaceuticals, Inc.

8119d0e1d8e.yskhbjppzg210z4cmmpP71HYrhMga_rs9cOQ1Qb8C9c.nYEYAwsbmEfR_n0szFo2pSSJ3mN0Kregp630s3-6fOeDqENedFqsfvmqDg~94ca573fb702f73c998351fc6c0e9f32

Upcoming events on Virpax Pharmaceuticals, Inc.

2024-05-13 Q1 2024 Earnings Release (Projected)
2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)

Past events on Virpax Pharmaceuticals, Inc.

2024-03-26 07:30 am Q4 2023 Earnings Release
2023-12-27 Extraordinary Shareholders Meeting
2023-11-15 04:15 pm Q3 2023 Earnings Release
2023-10-03 03:00 pm LD Micro Main Event Conference
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-14 09:00 am Q2 2023 Earnings Release
2023-07-24 10:30 am Annual General Meeting
2023-06-20 01:00 pm Maxim Group Virtual Healthcare Conference
2023-06-07 CB Tech Watch Seminar
2023-05-12 04:08 pm Q1 2023 Earnings Release
2023-05-11 10:45 am Sidoti Micro-Cap Virtual Conference
2023-03-22 08:58 am Q4 2022 Earnings Release
2022-11-09 09:00 am Q3 2022 Earnings Release
2022-08-15 09:00 am Interim 2022 Earnings Release
2022-05-24 07:00 am H.C. Wainwright Global Life Sciences Investment Conference
2022-05-16 09:00 am Q1 2022 Earnings Release
2022-03-31 09:00 am FY 2021 Earnings Release
2022-01-10 07:00 am H.C. Wainwright BioConnect Conference
2021-11-15 08:00 am Q3 2021 Earnings Release
2021-10-07 09:00 am Noble Capital Markets Pain Management Virtual Investor Forum

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-12,0
-11,9
-1.02%
-21,8
-26,6
17.76%
-15,7
-14,5
-8.19%

-17,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
-21,7
-26,5
18.25%
-15,2
-14,1
-7.54%

-17,4

Net income
Million USD
Released
Forecast
Spread
-4,34


0,00
0,00
-
-21,7
-26,5
18.25%
-15,2
-14,1
-7.54%

-17,4

EPS
USD
Released
Forecast
Spread
-14,0


0,00
0,00
-
-18,5
-22,6
18.14%
-13,0
-12,0
-8.08%

-8,20

Announcement Date31/03/2131/03/2222/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-



0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-4,12
-4,00
-3.04%



-5,90
-5,19
-13.69%
-7,72
-5,99
-28.8%
-3,10
-7,82
60.33%
-1,65
-3,48
52.56%
-3,24
-1,88
-72.5%



-4,68
-3,50
-33.98%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread






-5,88
-5,19
-13.32%
-7,64
-5,99
-27.58%
-2,99
-7,82
61.8%
-1,52
-3,48
56.31%
-3,11
-1,88
-65.75%



-4,56
-3,50
-30.48%
Net income
Million USD
Released
Forecast
Spread



-5,14


-5,88
-5,19
-13.32%
-7,64
-5,99
-27.58%
-2,99
-7,82
61.8%
-1,52
-3,48
56.31%
-3,11
-1,88
-65.75%



-4,56
-3,50
-30.48%
EPS
USD
Released
Forecast
Spread



-4,40


-5,00
-4,40
-13.64%
-6,50
-5,10
-27.45%
-2,60
-6,70
61.19%
-1,30
-3,00
56.67%
-2,70
-1,60
-68.75%



-12,1
-3,00
-302%
Announcement Date31/03/2216/05/2215/08/2209/11/2222/03/2312/05/2314/08/2326/12/2326/03/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. VRPX Stock
  4. Calendar Virpax Pharmaceuticals, Inc.